Tokyo Tape
Sign in
← Nihon Chouzai

Quarterly report · Q2

3341.TEDINET S100PM0M
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥152.3bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥299.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥146.2bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥2.8bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥2.4bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥2.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥6.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.5bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥2.9bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥1.6bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥187.6bnat 2022-09-30Cons.Assets
Total assets¥178.8bnat 2022-03-31Cons.Assets
Total assets¥184.4bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥133.6bnat 2022-09-30Cons.Liabilities
Total liabilities¥125.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥54.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥52.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥50.8bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥21.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥25.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥27.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥32.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥19.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥10.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥9.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥2.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥17.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥10.9bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥53.662022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.622022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.562021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.712021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.442021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio28.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio29.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio27.6%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥3.3bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥136.2bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥136.2bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥9m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥500m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥19.2bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.2bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2022-04-01 → 2022-09-30−¥396m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥159.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥152.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥9.9bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥9.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥3.3bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥128.7bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥128.7bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.6bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.6bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥440m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥23.7bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥13.8bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥9.9bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥195m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥156.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥146.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥5.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 515
ItemContextValueUnit
Work in processPrior1YearInstant1799000000JPY
Work in processCurrentQuarterInstant1602000000JPY
Raw materials and suppliesPrior1YearInstant6262000000JPY
Raw materials and suppliesCurrentQuarterInstant6372000000JPY
Other caPrior1YearInstant4121000000JPY
Other caCurrentQuarterInstant4203000000JPY
Allowance for doubtful accounts caPrior1YearInstant-8000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-7000000JPY
Current assetsPrior1YearInstant81651000000JPY
Current assetsCurrentQuarterInstant88123000000JPY
Buildings and structures netPrior1YearInstant29559000000JPY
Buildings and structures netCurrentQuarterInstant29556000000JPY
LandPrior1YearInstant14155000000JPY
LandCurrentQuarterInstant14002000000JPY
Construction in progressPrior1YearInstant1226000000JPY
Construction in progressCurrentQuarterInstant1381000000JPY
Other net ppePrior1YearInstant19083000000JPY
Other net ppeCurrentQuarterInstant18362000000JPY
Property plant and equipmentPrior1YearInstant64025000000JPY
Property plant and equipmentCurrentQuarterInstant63301000000JPY
GoodwillPrior1YearInstant15220000000JPY
GoodwillCurrentQuarterInstant15811000000JPY
Other iaPrior1YearInstant3749000000JPY
Other iaCurrentQuarterInstant4271000000JPY
Intangible assetsPrior1YearInstant18969000000JPY
Intangible assetsCurrentQuarterInstant20082000000JPY
Investment securitiesPrior1YearInstant16000000JPY
Investment securitiesCurrentQuarterInstant16000000JPY
Lease and guarantee depositsPrior1YearInstant8797000000JPY
Lease and guarantee depositsCurrentQuarterInstant9307000000JPY
Other ioaPrior1YearInstant5293000000JPY
Other ioaCurrentQuarterInstant6791000000JPY
Investments and other assetsPrior1YearInstant14107000000JPY
Investments and other assetsCurrentQuarterInstant16115000000JPY
Noncurrent assetsPrior1YearInstant97102000000JPY
Noncurrent assetsCurrentQuarterInstant99500000000JPY
AssetsPrior1YearInstant178753000000JPY
AssetsCurrentQuarterInstant187623000000JPY
Accounts payable tradePrior1YearInstant48513000000JPY
Accounts payable tradeCurrentQuarterInstant53957000000JPY
Electronically recorded obligations operating clPrior1YearInstant2862000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant2594000000JPY
Short term loans payablePrior1YearInstant1000000000JPY
Short term loans payableCurrentQuarterInstant1800000000JPY
Current portion of long term loans payablePrior1YearInstant12366000000JPY
Current portion of long term loans payableCurrentQuarterInstant11360000000JPY
Income taxes payablePrior1YearInstant1800000000JPY
Income taxes payableCurrentQuarterInstant1352000000JPY
Provision for bonusesPrior1YearInstant3861000000JPY
Provision for bonusesCurrentQuarterInstant4099000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass